Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Clinical Pharmacy and Therapeutics|July 31, 2013
Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and JapanR Shimazawa, M IkedaJournal of Clinical Pharmacy and Therapeutics|January 11, 2014
Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and JapanR Shimazawa, M IkedaJournal of Clinical Pharmacy and Therapeutics|May 4, 2018
Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labelsR Shimazawa, M IkedaJournal of Clinical Pharmacy and Therapeutics|October 25, 2011
Delays in psychiatric drug development in JapanR Shimazawa, I Kusumi, M IkedaBioorganic & Medicinal Chemistry Letters|March 31, 1999
Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogsR Shimazawa, H Takayama, F Kato, et al.Biological & Pharmaceutical Bulletin|April 1, 1995
Non-intercalative and sequence-selective interaction of nitropyrene/acridine-skeleton with nucleotides: application of the dextran-coupling methodM Shichita, R Shimazawa, O Nakajima, et al.Chemical & Pharmaceutical Bulletin|November 1, 1992
Syntheses of cerulenin and its analogs. II. Synthesis and biological activity of dl-carbacerulenin, a carbocyclic analog of ceruleninR Shimazawa, Y Ogawa, N Morisaki, et al.Nucleic Acids Symposium Series|January 1, 1995
Cytotoxicity and DNA-binding property of non-diynene class of dynemicins and aza-anthraquinonesR Shirai, R Shimazawa, M Shichita, et al.Biochemical and Biophysical Research Communications|October 15, 1991
Fluorescent probes for retinoic acid receptors: molecular measures for the ligand binding pocketR Shimazawa, S Hibino, H Mizoguchi, et al.Biological & Pharmaceutical Bulletin|March 17, 1999
Antiangiogenic activity of tumor necrosis factor-alpha production regulators derived from thalidomideR Shimazawa, H Miyachi, H Takayama, et al.Pageof 2